These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 234592)

  • 1. Letter: Beta-adrenergic blockade in hyperthyroidism.
    Cohen J
    N Engl J Med; 1975 Mar; 292(12):645-6. PubMed ID: 234592
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic beta adrenergic blockade in the preoperative treatment of hyperthyroidism.
    Brody AG; Dibble R
    Med Ann Dist Columbia; 1974 Feb; 43(2):72-4. PubMed ID: 4149916
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of adrenergic blockade by trimepranol and propranolol on protein iodine and the severity of thyrotoxicosis].
    Felt V; Vána S; Zamrazil V
    Cas Lek Cesk; 1971 Jun; 110(25):595-7. PubMed ID: 4103498
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta blockade in the management of thyrotoxicosis.
    Wilkinson R
    J Clin Hosp Pharm; 1983 Dec; 8(4):323-32. PubMed ID: 6141183
    [No Abstract]   [Full Text] [Related]  

  • 5. On the psychopharmacology of beta adrenergic blockade.
    Greenblatt DJ; Shader RI
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):615-25. PubMed ID: 4404445
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for the treatment of hyperthyroidism.
    Wartofsky L
    Am Fam Physician; 1984 Jul; 30(1):199-210. PubMed ID: 6205576
    [No Abstract]   [Full Text] [Related]  

  • 7. Adrenergic beta-receptor blockade in hyperthyroidism.
    Ramsay I
    Br J Clin Pharmacol; 1975 Oct; 2(5):385-8. PubMed ID: 9126
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of beta receptor blockaders on hyperthyroidism].
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Orv Hetil; 1979 May; 120(18):1080-2. PubMed ID: 35773
    [No Abstract]   [Full Text] [Related]  

  • 9. The use and abuse of beta-adrenergic blockade in the surgery of hyperthyroidism.
    Pimstone B; Joffe B
    S Afr Med J; 1970 Sep; 44(37):1059-61. PubMed ID: 4394421
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Hyperthyroidism.
    Obstet Gynecol; 1975 Jul; 46(1):112-4. PubMed ID: 239370
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of beta blockers in hyperthyroidism. Therapeutic relevance].
    Bouvier N; Millart H
    Therapie; 1998; 53(6):523-31. PubMed ID: 10070229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic-antagonist therapy for hyperthyroid Graves' disease.
    Utiger RD
    N Engl J Med; 1984 Jun; 310(24):1597-8. PubMed ID: 6145094
    [No Abstract]   [Full Text] [Related]  

  • 13. Interesting uses of beta blockers: 5 Beta blockers in thyrotoxicosis.
    Larkins RG; Heyma P
    Aust Fam Physician; 1981 Oct; 10(10):833-5. PubMed ID: 6118114
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol induced reduction in serum T3-A biochemical index of beta-adrenergic blockade in hyperthyroidism.
    Feely J
    Horm Metab Res; 1980; 12(6):279-80. PubMed ID: 6105995
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-adrenergic blockade for the treatment of hyperthyroidism.
    Geffner DL; Hershman JM
    Am J Med; 1992 Jul; 93(1):61-8. PubMed ID: 1352658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute effects of beta receptor blockaders in hyperthyroidism].
    Váradi A; Földes J; Gyertyánffy G; Borvendég J; Brüll J
    Orv Hetil; 1981 May; 122(18):1069-72. PubMed ID: 6115351
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-receptor blockaders in hyperthyreosis].
    Labhart A; Rothlin M
    Internist (Berl); 1978 Sep; 19(9):538-41. PubMed ID: 29853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thyreotoxicosis therapy with beta-blocking agents].
    Wahlberg P
    Duodecim; 1975; 91(10):637-9. PubMed ID: 240667
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.